Clinical Trial Detail

NCT ID NCT02711956
Title A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Zenith Epigenetics Corp.
Indications

prostate cancer

Therapies

Enzalutamide + ZEN-3694

Age Groups: adult

No variant requirements are available.